{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:55:32Z","timestamp":1782320132040,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.vaccine.2006.10.028","type":"journal-article","created":{"date-parts":[[2006,11,14]],"date-time":"2006-11-14T15:22:02Z","timestamp":1163517722000},"page":"1470-1475","source":"Crossref","is-referenced-by-count":62,"title":["Tick-borne encephalitis (TBE) vaccination: Applying the most suitable vaccination schedule"],"prefix":"10.1016","volume":"25","author":[{"given":"I.","family":"Sch\u00f6ndorf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Beran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Cizkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Lesna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Banzhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Zent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"December (12)","key":"10.1016\/j.vaccine.2006.10.028_bib1","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1469-0691.2004.01022.x","article-title":"Tick-borne virus diseases of human interest in Europe","volume":"10","author":"Charrel","year":"2004","journal-title":"Clin Microbiol Infect"},{"issue":"June (26)","key":"10.1016\/j.vaccine.2006.10.028_bib2","article-title":"Tick-borne encephalitis in the Czech Republic","volume":"8","author":"Beran","year":"2004","journal-title":"Eurosurveillance Wkly"},{"issue":"March (13)","key":"10.1016\/j.vaccine.2006.10.028_bib3","article-title":"Tick-borne encephalitis in the Czeck Republic-advice for travelers","volume":"5","author":"Beran","year":"2001","journal-title":"Eurosurveillance Wkly"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2006.10.028_bib4","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1469-0691.2005.01115.x","article-title":"Immunisation against tick-borne encephalitis by widely used vaccines: short-term history and current recommendations","volume":"11","author":"Beran","year":"2005","journal-title":"Clin Microbiol Infect"},{"issue":"November (46)","key":"10.1016\/j.vaccine.2006.10.028_bib5","first-page":"601","article-title":"Current trends field evaluations of pre-exposure use of human diploid cell rabies vaccine","volume":"32","author":"CDC","year":"1983","journal-title":"MMWR"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2006.10.028_bib6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-1157(89)80004-6","article-title":"Preclinical investigations of the safety, immunogenicity and efficacy of a purified, inactivated tick-borne encephalitis vaccine","volume":"17","author":"Klockmann","year":"1989","journal-title":"J Biol Stand"},{"issue":"September (25\u201326)","key":"10.1016\/j.vaccine.2006.10.028_bib7","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1016\/S0264-410X(03)00421-3","article-title":"Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer","volume":"21","author":"Zent","year":"2003","journal-title":"Vaccine"},{"issue":"January (7\u20138)","key":"10.1016\/j.vaccine.2006.10.028_bib8","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0264-410X(02)00592-3","article-title":"Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults","volume":"21","author":"Zent","year":"2003","journal-title":"Vaccine"},{"issue":"November (46)","key":"10.1016\/j.vaccine.2006.10.028_bib9","first-page":"601","article-title":"Current trends field evaluations of pre-exposure use of human diploid cell rabies vaccine","volume":"32","author":"CDC","year":"1983","journal-title":"MMWR"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2006.10.028_bib10","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4269\/ajtmh.1999.61.288","article-title":"Japanese encephalitis vaccine (inactivated, BIKEN) in U.S. soldiers: immunogenicity and safety of vaccine administered in two dosing regimens","volume":"61","author":"Defraites","year":"1999","journal-title":"Am J Trop Med Hyg"},{"issue":"October (15)","key":"10.1016\/j.vaccine.2006.10.028_bib11","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/S0264-410X(96)00081-3","article-title":"Tick-borne encephalitis: development of a paediatric vaccine. A controlled, randomized, double-blind and multicentre study","volume":"14","author":"Girgsdies","year":"1996","journal-title":"Vaccine"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2006.10.028_bib12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0264-410X(90)90172-I","article-title":"A new vaccine against tick-borne encephalitis: initial trial in man including a dose\u2013response study","volume":"8","author":"Bock","year":"1990","journal-title":"Vaccine"},{"issue":"December (2)","key":"10.1016\/j.vaccine.2006.10.028_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0264-410X(03)00563-2","article-title":"Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity","volume":"22","author":"Ehrlich","year":"2003","journal-title":"Vaccine"},{"issue":"December (3)","key":"10.1016\/j.vaccine.2006.10.028_bib14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.vaccine.2004.06.007","article-title":"TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?","volume":"23","author":"Zent","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.10.028_bib15","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.vaccine.2004.01.041","article-title":"Persistence of protective immunity following vaccination against tick-borne encephalitis\u2014longer than expected?","volume":"22","author":"Rendi-Wagner","year":"2004","journal-title":"Vaccine"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2006.10.028_bib16","doi-asserted-by":"crossref","first-page":"874","DOI":"10.4269\/ajtmh.1999.61.874","article-title":"An accelerated schedule for tick-borne encephalitis vaccine: the American Military experience in Bosnia","volume":"61","author":"Craig","year":"1999","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2006.10.028_bib17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0264-410X(92)90003-3","article-title":"A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens","volume":"10","author":"Harabacz","year":"1992","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2006.10.028_bib18","first-page":"41","article-title":"FSME-IMMUN\u00ae Erwachsene: Der, neue\u201d FSME-Impfstoff von Baxter","volume":"18","author":"Ehrlich","year":"2002","journal-title":"Ellipse"},{"issue":"S1","key":"10.1016\/j.vaccine.2006.10.028_bib19","first-page":"213","article-title":"Immunogenicity and safety of FSME-Immun 0.5mL using a rapid immunizaiton schedule","volume":"296","author":"Loew-Baselli","year":"2006","journal-title":"Int J Med Microbiol"},{"issue":"December (32)","key":"10.1016\/j.vaccine.2006.10.028_bib20","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1016\/j.vaccine.2003.08.005","article-title":"Kinetics of the immune response after primary and booster immunization against tick-borne encephalitis (TBE) in adults using the rapid immunization schedule","volume":"21","author":"Zent","year":"2003","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06011522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06011522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T09:59:51Z","timestamp":1555927191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06011522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0264410X06011522"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.10.028","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}